In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis
- 1 March 1997
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (3) , 593-605
- https://doi.org/10.1016/s0168-8278(97)80425-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancerInternational Journal of Cancer, 1995
- Degradation of vitronectin by matrix metalloproteinases‐1, ‐2, ‐3, ‐7 and ‐9FEBS Letters, 1995
- Cell surface binding of TIMP‐2 and pro‐MMP‐2/TIMP‐2 complexFEBS Letters, 1995
- Current concepts in metastasis.Gut, 1994
- Researchers Test TIMP-2 as Potential Tumor TerminatorJNCI Journal of the National Cancer Institute, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- TIMP-2, a Growth-Stimulatory Protein from SV40-Transformed Human FibroblastsExperimental Cell Research, 1993
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984